Lower death risk by adding azithromycin to HIV treatment
Treatments studied
Part of Immune system & allergy, Infections clinical trials.
This Phase 3 study tests whether adding azithromycin helps people with advanced HIV disease live longer. You would start (or restart or adjust) HIV treatment within 4 weeks and may also receive azithromycin or a comparison approach to see if outcomes improve.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a documented HIV infection
- Your recent HIV immune strength (CD4) is very low—about 100 or less, or you have a past low CD4 plus stopped HIV meds for at least 6 months
- You can start, restart, or change HIV medicines to a working plan within 4 weeks of enrolling
- You do not have a known allergy to azithromycin (or similar antibiotics like erythromycin or macrolides)
- You do not have a personal or family history of heart rhythm trouble called long QT
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 4 study tests whether a long course of azithromycin can reduce flare-ups in people with chronic obstructive pulmonary disease (COPD) who have had recent exacerbations. It also looks at mucus properties and how flare-ups happen.
This Phase 3 study tests an enhanced clinic care package for adults with advanced HIV to lower the risk of death. It may help by improving follow-up and treatment support for people who need closer care.
This Phase 4 study looks at optimizing how people with COPD take azithromycin to reduce flare-ups (exacerbations). If you already take azithromycin regularly, the trial may test ways to improve how it’s used safely.
This Phase 3 study looks at antiretroviral treatment (HIV medicines) for adults with either recent (acute) or long-term (chronic) HIV. It’s designed to see how well and safely ongoing HIV treatment works, and it may help you get structured care and monitoring.
This study looks at people with advanced HIV disease during their first months on antiretroviral therapy (ART). It aims to understand and improve care for those who start treatment when their immune system is weak.
This trial tests whether taking zinc supplements helps HIV patients who have low CD4 cell counts even when their virus is well-controlled. If your zinc levels are normal but your immune cells are slow to recover, this might be for you.
Hear when a new HIV Disease Progression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.